Understanding Your HER2 Status: The Key to Targeted Breast Cancer Treatment
Receiving a breast cancer diagnosis brings many questions and concerns, but knowing your HER2 status provides one of the most important answers for your treatment journey. This specialised test isn’t just about diagnosis – it’s about finding the most effective path forward for your unique situation.
What This Test Reveals About Your Breast Cancer
The HER2/ERBB2 Immunohistochemistry Test examines your breast tissue sample to detect whether your cancer cells have too much HER2 protein. Think of HER2 as a “growth signal” – when there’s too much, cancer cells grow and divide more aggressively. This test helps your medical team understand exactly what they’re dealing with, allowing for personalised treatment planning that targets your specific cancer type.
Using advanced immunohistochemistry technology, our expert pathologists analyse your tissue sample with precision, providing results that directly influence whether targeted therapies like Herceptin will be effective for your treatment.
Who Should Consider This Essential Test?
This test is crucial for anyone recently diagnosed with breast cancer or those whose cancer has returned. If you’re experiencing:
- Newly diagnosed invasive breast cancer
- Recurrent breast cancer requiring updated treatment planning
- Uncertainty about which treatment options will work best
- The need for clarity on whether targeted therapies are appropriate
Your HER2 status isn’t just another test result – it’s a roadmap that guides your entire treatment strategy, potentially saving you from ineffective treatments and unnecessary side effects.
Why Knowing Your HER2 Status Matters for Your Recovery
Understanding your HER2 status transforms uncertainty into actionable information. HER2-positive breast cancers respond remarkably well to targeted therapies that specifically block the HER2 protein, often leading to better outcomes with fewer side effects than traditional chemotherapy alone.
This knowledge provides:
- Personalised Treatment: Avoid one-size-fits-all approaches
- Targeted Therapy Options: Access treatments designed for your cancer type
- Reduced Treatment Guesswork: Make informed decisions with confidence
- Peace of Mind: Know you’re pursuing the most effective path
Understanding Your Results: Clear Guidance Every Step
We know waiting for results can be anxiety-provoking, which is why we provide clear, comprehensive reports that your oncologist can easily interpret. Your results will clearly indicate whether your cancer is HER2-positive or HER2-negative, with detailed explanations that help you understand what this means for your treatment options.
Our pathology team includes this test in their routine analysis, ensuring you receive accurate, reliable information backed by medical expertise. Remember: a positive HER2 result opens the door to highly effective targeted treatments that have transformed outcomes for thousands of South African women.
Transparent Pricing – Investing in Your Health Future
| Test Description | Regular Price | Special Price | Turnaround Time |
|---|---|---|---|
| HER2/ERBB2 Breast Cancer Test | ZAR 650 | 5-7 days |
Considering that targeted therapy decisions based on this test can significantly impact treatment effectiveness and potentially reduce overall healthcare costs, this investment in precise diagnostics provides exceptional value for your health journey.
Why Trust Oracle Genomics With Your Cancer Testing?
We understand that cancer testing requires absolute accuracy and reliability. Our nationwide network ensures accessibility whether you’re in Johannesburg, Cape Town, Durban, or Pretoria. Every test is processed by experienced pathologists specialising in cancer diagnostics, using validated methods that meet international standards.
Sample Requirements: Submit tumor tissue in 10% formal-saline OR formalin fixed paraffin embedded block. Please include a copy of your histopathology report, biopsy site information, and clinical history for comprehensive analysis.
Turnaround Times: Tissue biopsy: 5 days | Complex tissue: 7 days | Samples accepted daily until 6 PM
Take Control of Your Treatment Journey Today
Don’t leave your treatment decisions to chance. Knowing your HER2 status could be the difference between guessing and knowing which path will work best for you. With convenient locations across South Africa and results within 5-7 days, there’s no reason to delay this crucial step in your cancer care.
Book your HER2 test today and give yourself the clarity needed for effective treatment planning. Our team is ready to support you through this process with the compassion and expertise you deserve.
